Axillary Hyperhidrosis Clinical Trial
Official title:
The Use of the VASER System in the Treatment of Axillary Hyperhidrosis and/or Axillary Bromidrosis
Patients with excessive underarm odor and sweating and/or odor are treated with the VASER system to determine the VASER's effectiveness in reducing underarm sweat and odor
Patients with excessive underarm sweat and/or odor are recruited. The effect that excessive underarm sweat and/or odor has on their lifestyle is evaluated. They are surgically treated with the VASER system and followed up for 6 months to evaluate side effects, adverse events and effectiveness. Additional lifestyle evaluations are completed for comparison to pre-surgery answers. ;
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04546438 -
Patient Satisfaction and Safety of Miradry Treatment for Axillary Hyperhidrosis
|
N/A | |
Completed |
NCT03836287 -
Safety and Efficacy Study of Sofpironium Bromide in Subjects With Axillary Hyperhidrosis (BBI-4000-CL-301)
|
Phase 3 | |
Enrolling by invitation |
NCT02105753 -
Tx Axillary Hyperhidrosis 1210nm Diode Laser
|
N/A | |
Withdrawn |
NCT05546710 -
miraDry Post Market Tumescent Anesthesia Study
|
N/A | |
Active, not recruiting |
NCT02295891 -
Miradry Treatment for Focal Axillary Hyperhidrosis
|
N/A | |
Completed |
NCT01118429 -
Use of Oxybutynin to Treat Axillary Hyperhidrosis
|
N/A | |
Completed |
NCT01091129 -
Clinical Evaluation of the miraDry System in Subjects With Hyperhidrosis
|
N/A | |
Completed |
NCT03948646 -
Safety and Efficacy Study of Sofpironium Bromide in Subjects With Axillary Hyperhidrosis (BBI-4000-CL-302)
|
Phase 3 | |
Completed |
NCT01274611 -
Botox and Suction-Curettage for Treatment of Excessive Underarm Sweating (Axillary Hyperhidrosis)
|
N/A | |
Completed |
NCT03320096 -
Evaluation of the Ulthera System for Treating Axillary Hyperhidrosis
|
N/A |